NEW ORLEANS, LA – October 2024 – Fluoriq was honored to have its Chief Science Officer, Dr. David Colby, present the company's latest project at BIO on the BAYOU, a premier event highlighting emerging biotech and health-related research from the Gulf South region. Held in New Orleans, this annual event, which began in 2020, serves as a dynamic platform for universities and small companies to showcase their groundbreaking work, with a focus on underrepresented yet promising innovations in the biotech industry.
Fluoriq has developed a technology platform that enhances pharmaceutical manufacturing and facilitates the design of new biotechnology products through the discovery of innovative solvents.
As a company, we are proud to be part of a vibrant ecosystem of researchers, entrepreneurs, and scientists pushing the boundaries of what's possible in biotech. BIO on the Bayou continues to be a key event for showcasing the untapped potential in the Gulf South, and we look forward to the ongoing collaborations and discoveries that will emerge from this region. We’re excited about what lies ahead and grateful for the opportunity to be part of this growing movement. See you in New Orleans at BIO on the Bayou 2025!
OXFORD, Miss - 2024- A University of Mississippi pharmacy professor has been selected for the NIH-funded I-RED (Innovative Research and Entrepreneurship Development) program’s inaugural cohort. The program, aimed at fostering innovation in life sciences, provides selected entrepreneurs with resources such as funding, mentorship, and networking opportunities to advance their technologies. Dr. David Colby, Chief Science Officer at Fluoriq, is one of the innovators chosen for the cohort. His work in developing novel solvents to enhance pharmaceutical manufacturing and biotechnology design will be further supported by the program, marking an important step forward in advancing cutting-edge solutions within the biotech industry.
OXFORD, Miss- January 2024- A University of Mississippi pharmacy professor has been named to the inaugural cohort of the NIH-funded I-RED (Innovative Research and Entrepreneurship Development) program. This prestigious initiative supports early-stage life sciences innovators by providing essential resources such as mentorship, funding, and networking opportunities. Dr. David Colby, Chief Science Officer at Fluoriq, is among the selected entrepreneurs. His groundbreaking work in developing innovative solvents to enhance pharmaceutical manufacturing and biotechnology applications will receive valuable support through this program, further advancing the potential of his pioneering research.
LOUISVILLE, Ky -October 2023 -The XLerator Network has selected nine innovators across the Southeast for the inaugural cohort of its NIH-funded entrepreneurship program, I-RED (Innovative Research and Entrepreneurship Development). This program aims to support the growth of early-stage technologies and businesses in the life sciences. Among those recognized is Dr. David Colby, Chief Science Officer at Fluoriq, whose groundbreaking work in innovative solvent technologies plays a critical role in advancing pharmaceutical manufacturing and biotechnology. As part of this prestigious cohort, Dr. Colby and his team at Fluoriq will benefit from mentorship, funding, and networking opportunities designed to accelerate the commercialization of their pioneering technologies. This initiative is a key step in fostering innovation and entrepreneurship in the Gulf South region and beyond.
Copyright © 2025 Fluoriq - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.